BSEBoard Meeting21h ago · 30 Oct 2026, 06:21 pm
Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this to inform you that a meeting of the Board of Directors of the Company will be held on Friday, November 06, 2026, inter alia to Consider and approve the Unaudited Financial Results ....
Supriya Lifescience Ltd · 543434
✦ AI SummaryResults
Supriya Lifescience Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Quarter And Half Year Ended September 30, 2026
Attachments (1)
📄pdf
Download →
9359503e-bae4-4849-b7c1-e1c7e9a37398.pdf
View document text
October 30, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street, Bandra Kurla Complex
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543434 Scrip Symbol: SUPRIYA
Dear Sir(s),
Sub: Intimation of Board Meeting
In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
this to inform you that a meeting of the Board of Directors of the Company will be held on Friday,
November 06, 2026, inter alia to Consider and approve the Unaudited Financial Results of the Company
for the quarter and half year ended September 30, 2026.
This is to further inform you that in accordance with the Company’s Code of Conduct for Prevention of
Insider Trading, the 'Trading Window’ for dealing in securities of the Company by Designated Persons
and their immediate relatives is closed from October 1, 2026, till 48 hours after declaration of Unaudited
Financial Results on November 06, 2026.
Kindly take the above information on your records.
Thanking you,
Yours faithfully,
For Supriya Lifescience Limited
Prachi Sathe
Company Secretary & Compliance Officer
Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India.
Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX
CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India.
Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com
GOVT. RECOGNISED EXPORT HOUSE